American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Ecovyst
ECVT
$1.14B
| $1.65M | ﹤0.01% |
184,125
+21,032
| +13% | +$203K |
|
1977
Haemonetics
HAE
$4.13B
| $1.65M | ﹤0.01% |
19,931
-1,066
| -5% | -$93.8K |
|
1978
Iovance Biotherapeutics
IOVA
$3.16B
| $1.63M | ﹤0.01% |
203,038
-135,478
| -40% | -$1.45M |
|
1979
Huntsman Corp
HUN
$1.81B
| $1.62M | ﹤0.01% |
71,208
-3,260
| -4% | -$79.4K |
|
1980
Omnicell
OMCL
$1.7B
| $1.61M | ﹤0.01% |
59,334
+12,734
| +27% | +$369K |
|
1981
PJT Partners
PJT
$4.46B
| $1.6M | ﹤0.01% |
14,837
+120
| +0.8% | +$12.1K |
|
1982
CBIZ
CBZ
$2.96B
| $1.6M | ﹤0.01% |
21,566
-18,428
| -46% | -$1.39M |
|
1983
Hawaiian Electric Industries
HE
$2.03B
| $1.6M | ﹤0.01% |
177,049
+21,584
| +14% | +$224K |
|
1984
Royalty Pharma
RPRX
$26.1B
| $1.59M | ﹤0.01% |
60,468
+6,955
| +13% | +$193K |
|
1985
Liberty Broadband Class C
LBRDK
$5.21B
| $1.59M | ﹤0.01% |
29,050
+829
| +3% | +$42.8K |
|
1986
Whirlpool
WHR
$2.7B
| $1.59M | ﹤0.01% |
15,557
-299
| -2% | -$29.1K |
|
|
ORLA
1987
DELISTED
Orla Mining
ORLA
| $1.58M | ﹤0.01% |
412,400
+17,100
| +4% | +$68.5K |
|
1988
Celanese
CE
$5.01B
| $1.58M | ﹤0.01% |
11,683
-402
| -3% | -$61.4K |
|
1989
Marqeta
MQ
$1.7B
| $1.57M | ﹤0.01% |
71,503
+47,470
| +198% | +$1.05M |
|
1990
NCR Voyix
VYX
$1.13B
| $1.55M | ﹤0.01% |
125,905
-53,493
| -30% | -$674K |
|
|
PARA
1991
DELISTED
Paramount Global Class B
PARA
| $1.55M | ﹤0.01% |
149,144
+1,984
| +1% | +$23.2K |
|
1992
Roku
ROKU
$23.4B
| $1.55M | ﹤0.01% |
25,847
+877
| +4% | +$51.4K |
|
1993
PCB Bancorp
PCB
$399M
| $1.54M | ﹤0.01% |
94,811
+36
| +0% | +$550 |
|
|
TBCH
1994
Turtle Beach Corp
TBCH
$228M
| $1.54M | ﹤0.01% |
107,221
-85,489
| -44% | -$1.33M |
|
1995
IDT Corp
IDT
$1.66B
| $1.53M | ﹤0.01% |
42,567
+3,279
| +8% | +$123K |
|
1996
Vanda Pharmaceuticals
VNDA
$316M
| $1.53M | ﹤0.01% |
269,971
+18,733
| +7% | +$96.8K |
|
1997
RH
RH
$3.44B
| $1.53M | ﹤0.01% |
6,240
-528
| -8% | -$139K |
|
1998
Asbury Automotive
ABG
$3.78B
| $1.52M | ﹤0.01% |
6,687
-2,028
| -23% | -$460K |
|
1999
Dolby
DLB
$5.84B
| $1.52M | ﹤0.01% |
19,148
+800
| +4% | +$64.4K |
|
2000
Morningstar
MORN
$7.78B
| $1.51M | ﹤0.01% |
5,115
+2,678
| +110% | +$793K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.